Neurocognitive consequences of cigarette smoking in young adults—a comparison with pre-drug performance

doi:10.1016/j.ntt.2006.06.003

Neurotoxicology and Teratology

Volume 28, Issue 4, July–August 2006, Pages 517-525

https://doi.org/10.1016/j.ntt.2006.06.003 Get rights and content

Abstract

The present study examined effects of current and past regular cigarette smoking in young adult subjects. One hundred and twelve 17–21-year-old subjects, assessed since infancy, were evaluated using a battery of neurocognitive tests for which commensurate measures were obtained at 9–12 years of age, prior to the initiation of regular smoking. Smokers, determined by urinalysis and self-report, were categorized as heavy (> 9 cigarettes per day) and light (< 9 cigarettes per day) current smokers and former smokers, the latter having smoked cigarettes regularly in the past but not for at least 6 months. A third of the subjects were currently smoking cigarettes regularly with half of these being heavy smokers. Among former smokers, the average duration of smoking was slightly less than 2 years. Overall IQ, memory, processing speed, vocabulary, attention and abstract reasoning were the primary outcomes with comparisons being made between each of the three user groups and a control group who never smoked regularly. After accounting for potentially confounding factors including clinical assessment, marihuana use and pre-drug performance in the relevant cognitive domain, current regular smokers did significantly worse than non-smokers in a variety of cognitive areas predicated upon verbal/auditory competence including receptive and expressive vocabulary, oral arithmetic, and auditory memory. This impact of current smoking appears to behave in a dose–response and duration-related fashion. In contrast, former smokers differed from the non-smokers only in the arithmetic task. These results suggest that regular smoking during early adulthood is associated with cognitive impairments in selected domains and that these deficits may be reversed upon cessation. Together, the findings add to the body of evidence to be used in persuading adolescents and young adults against the initiation of smoking and, if currently smoking, the advantages of stopping.

Introduction

In North America, smoking among adolescents and young adults rose sharply in the 1990s reaching a peak in 1997. Subsequent to that period, although regular tobacco use has declined in these age groups, the rate of decline has decelerated sharply in the past 2 years. Recent observations derived from surveys conducted in both the United States [29] and Canada [4] have indicated that, among older adolescents, the current smoking proportion is 16% and 18%, respectively. The Canadian survey noted that 27% of 20–24-year-olds smoked. For several decades, the perception of risk has been observed to parallel the trends noted in smoking rates [29] suggesting that the perceived dangers play an important role in determining whether this habit becomes part of the lifestyle of the adolescent and young adult. Although there is incontrovertible evidence that smoking is the greatest preventable cause of disease and mortality, the putative impact of cigarette use by adolescents and young adults on cognitive performance is not as clearly defined. If such a relationship could be firmly established it may serve as an important addition to the perception of risk of this habit.

Most studies investigating the association between smoking and cognitive functioning have focused upon the impact of cigarettes in the elderly population using both cross-sectional (e.g., [9], [10]) and longitudinal approaches (e.g., [6], [31]). Although not entirely consistent [3] current smoking is reported, in the majority of these studies, to affect cognitive function in a detrimental fashion. Among 80-year-olds, a recent report [8] noted reduced cognitive scores in current but not previous smokers. In this work, cognitive assessments for the subjects were statistically adjusted for mental abilities assessed at 11 years of age.

A few studies have examined cigarette smoking in relation to cognitive performance in middle age subjects. A battery of tests in a variety of cognitive domains was administered by Kalmijn et al. [30] to 45–70-year-olds using a cross-sectional design. Current smokers were found to have, in a dose–response relationship, reduced psychomotor speed and reduced cognitive flexibility. Former smokers had scores that were intermediate between those of the smokers and non-smokers. In a longitudinal, birth cohort study [40], the association between cigarette smoking and a number of cognitive outcomes was investigated in middle-aged subjects. Smoking more than 20 cigarettes per day was associated with faster declines in verbal memory and slower visual search speeds. The findings were independent of sex, years of education, socioeconomic status and cognitive abilities assessed at age 15.

Information regarding the possible impact of smoking upon adolescents' cognitive performance is limited to the recent observations in 14–18-year-olds reported by Jacobsen et al. [27]. In this cross-sectional study, after controlling for general intelligence, alcohol and marihuana use, adolescent daily smokers, compared to nonsmokers, were found to have impairments in working memory but not aspects of attention or short-term memory irrespective of recency of smoking. Performance decrements were more marked with an earlier age of onset of smoking. In this work presmoking cognitive abilities were not available.

The present study examines the impact of cigarettes upon neurocognitive functioning in young adults. The subjects are members of families recruited in the late 1970s and early 1980s and have been assessed since birth while participating in the Ottawa Prenatal Prospective Study (OPPS). These young adult offspring can now serve as a valuable cohort for the evaluation of the cognitive consequences of their own drug use. The strength of using these subjects includes the rapport established over many test sessions and the extensive background information that has been gathered in a prospective fashion including cognitive abilities prior to the onset of drug use, prenatal exposure to various substances, socioeconomic variables, and other potentially confounding factors.

Recently, we have described the impact of marihuana upon overall IQ [20] and a variety of specific cognitive domains [19] in 17–21-year-olds. In this birth cohort, smoking marihuana five or more times a week was associated with lower scores on global IQ, visual processing speed, and both immediate and delayed memory after controlling for potentially confounding factors and corresponding cognitive measures obtained when the same subjects were 9–12 years of age [17]. Among subjects who were former heavy marihuana users but had not consumed the drug for at least 3 months prior to assessment, no cognitive impairments were observed.

The objectives of the current study are to determine whether, in the same sample with similar prospectively gathered background data, current and former cigarette smoking impacts upon various, specific cognitive domains in young adults.

Section snippets

Participants

The Ottawa Prenatal Prospective Study (OPPS) began in 1978 with the major objective of examining the effects on children of cigarette smoking, marihuana, and alcohol use by their mothers during pregnancy. The method of recruitment of the pregnant women, the determination of their drug use, and the study results have been reported elsewhere (e.g., [12], [16]). Approximately 160 children have been administered neuropsychological tests yearly to age 7 and once during each of the 9–12-, 13–16-, and

Sample characteristics

Sample characteristics across the smoking groups are described in Table 2b. Maternal nicotine and marihuana use variables were coded for the analyses, as described in previous publications (e.g., [17]), in order to reduce skewness and outlier effects. The frequency of positive diagnoses for each of the DSM-IV disorders was low and to use this variable as a covariate, a dichotomous measure as described previously [19] was created whereby each subject with one or more positive diagnoses was

Discussion

Using a sample of young adults who have been assessed since birth, the present study offered the unique opportunity of assessing a number of cognitive outcomes in young adult smokers and former smokers for whom evaluation within the same cognitive domains had taken place prior to the onset of regular smoking. Furthermore, the longitudinal, prospective design included assessment of possible confounding variables important in the interpretation of the findings.

The major impact of the quantity and

Acknowledgement

This work was supported by a research grant to P.A.F. from the National Institute on Drug Abuse. The authors thank H. Linttell for her continuing invaluable assistance in data collection as well as the families for their ongoing participation in the OPPS since the early 1980s.

References (48)

L.F. Berkman et al.
High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging
J. Clin. Epidemiol.
(1993)
P.A. Fried et al.
12- and 24-month neurobehavioral follow-up of children prenatally exposed to marihuana, cigarettes and alcohol
Neurotoxicol. Teratol.
(1988)
P.A. Fried et al.
Changing patterns of soft drug use prior to and during pregnancy: a prospective study
Drug Alcohol Depend.
(1980)
P.A. Fried et al.
Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana
Neurotoxicol. Teratol.
(1998)
P.A. Fried et al.
Differential effects on cognitive functioning in 13- to 16-year olds prenatally exposed to cigarettes and marihuana
Neurotoxicol. Teratol.
(2003)
P.A. Fried et al.
The neurocognitive consequences of marijuana—a comparison with pre-drug use performance
Neurotoxicol. Teratol.
(2005)
P.A. Fried et al.
Reading and language in 9 to12-year-olds prenatally exposed to cigarettes and marijuana
Neurotoxicol. Teratol.
(1997)
L.K. Jacobsen et al.
Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers
Biol. Psychiatry
(2005)
J.S. McCartney et al.
Central auditory processing in school-age children prenatally exposed to cigarette smoke
Neurotoxicol. Teratol.
(1994)
B.J. Morley
Nicotinic cholinergic intercellular communication: implications for the developing auditory system
Hear. Res.
(2005)

A.J. Porath et al.

Effects of prenatal cigarette and marijuana exposure on drug use among offspring

Neurotoxicol. Teratol.

(2005)

T.A. Slotkin

Nicotine and the adolescent brain: insights from an animal model

Neurotox. Teratol.

(2002)

Y. Abreu-Villca et al.

Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations

Brain Res.

(2003)

American Psychiatric Association

Diagnostic and Statistical Manual of Mental Disorders

(1994)

Canadian Tobacco Use Monitoring Survey

(2004)

Computerized NIMH-Diagnostic Interview Schedule for Children-Version IV (C-DISC 4)

(1997)

J.A. Cervilla et al.

Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak Project

J. Neurol. Neurosurg. Psychiatry

(2000)

M.D. Cornelius et al.

Prenatal tobacco exposure: is it a risk for early tobacco experimentation?

Nicotine Tob. Res.

(2000)

I.J. Deary et al.

Smoking and cognitive change from age 11 to age 80

J. Neurol. Neurosurg. Psychiatry

(2005)

S.L. Edelstein et al.

Prospective association of smoking and alcohol use with cognitive function in an elderly cohort

J. Women's Health

(1998)

M.F. Elias et al.

The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort

Arch. Neurol.

(2000)

K.R. Fogelman et al.

Smoking in pregnancy and development into early childhood

BMJ

(1988)

P.A. Fried

Adolescents prenatally exposed to marijuana: Examination of facets of complex behaviors and comparison with the influence of in utero cigarettes

J. Clin. Pharmacol.

(2002)

P.A. Fried et al.

60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes and alcohol: Cognitive and language assessment

J. Dev. Behav. Pediatr.

(1992)

Cited by (60)

Genetic influences impacting nicotine use and abuse during adolescence: Insights from human and rodent studies
2022, Brain Research Bulletin
Citation Excerpt :
These long-term consequences of nicotine use and abuse during this period of brain maturation could be driven by nicotine, a toxic and psychoactive substance, altering the trajectory of brain development. Children and adolescents are more susceptible than adults to developing nicotine addiction and to long-term mental health problems associated with nicotine use (Bandiera et al., 2011; Counotte et al., 2009; Fried et al., 2006; Jacobsen et al., 2005). This increased vulnerability to negative health outcomes associated with nicotine use could be because the brain continues to develop well into the teenage years (Benes et al., 1994; Casey et al., 2005; Koshibu et al., 2004; Spear, 2013; Zehr et al., 2008).
Nicotine use continues to be a major public health concern, with an alarming recent rise in electronic cigarette consumption. Heritability estimates of nicotine use and abuse range from 40% to 80%, providing strong evidence that genetic factors impact nicotine addiction-relevant phenotypes. Although nicotine use during adolescence is a key factor in the development of addiction, it remains unclear how genetic factors impact adolescent nicotine use and abuse. This review will discuss studies investigating genetic factors impacting nicotine use during adolescence. Evidence from both rodent and human studies will be summarized and integrated when possible. Human adolescent studies have largely included candidate gene studies for genes identified in adult populations, such as genes involved in nicotine metabolism, nicotinic acetylcholine receptor signaling, dopaminergic signaling, and other neurotransmitter signaling systems. Alternatively, rodent studies have largely taken a discovery-based approach identifying strain differences in adolescent nicotine addiction-relevant behaviors. Here, we aim to answer the following three questions by integrating human and rodent findings: (1) Are there genetic variants that uniquely impact nicotine use during adolescence? (2) Are there genetic variants that impact both adolescent and adult nicotine use? and (3) Do genetic factors in adolescence significantly impact long-term consequences of adolescent nicotine use? Determining answers for these three questions will be critical for the development of preventative measures and treatments for adolescent nicotine use and addiction.
Testing the association between tobacco and cannabis use and cognitive functioning: Findings from an observational and Mendelian randomization study
2021, Drug and Alcohol Dependence
Although studies have examined the association between tobacco and cannabis use in adolescence with subsequent cognitive functioning, study designs are usually not able to distinguish correlation from causation.
Separate patterns of tobacco and cannabis use were derived using longitudinal latent class analysis based on measures assessed on five occasions from age 13–18 in a large UK population cohort (Avon Longitudinal Study of Parents and Children). Cognitive functioning measures comprised of working memory, response inhibition, and emotion recognition assessed at 24 years of age. Mendelian randomization was used to examine the possible causal relationship between smoking initiation, lifetime cannabis use and cognitive functioning.
We found evidence of a relationship between tobacco and cannabis use and diminished cognitive functioning for each of the outcomes in the observational analyses. There was evidence to suggest that late-onset regular tobacco smokers (b=-0.29, 95 %CI=-0.45 to -0.13), early-onset regular tobacco smokers (b=-0.45, 95 %CI=-0.84 to -0.05), and early-onset regular cannabis users (b=-0.62, 95 %CI=-0.93 to -0.31) showed poorer working memory. Early-onset regular tobacco smokers (b = 0.18, 95 %CI = 0.07 to 0.28), and early-onset regular cannabis users (b = 0.30, 95 %CI = 0.08 to 0.52) displayed poorer ability to inhibit responses. Late-onset regular (b=-0.02, 95 %CI=-0.03 to - 0.00), and early-onset regular tobacco smokers (b=-0.04, 95 %CI=-0.08 to -0.01) showed poorer ability to recognise emotions. Mendelian randomization analyses were imprecise and did not provide additional support for the observational results.
There was some evidence to suggest that adolescent tobacco and cannabis use were associated with deficits in working memory, response inhibition and emotion recognition. Better powered genetic studies are required to determine whether these associations are causal.
Adolescent drug exposure: A review of evidence for the development of persistent changes in brain function
2020, Brain Research Bulletin
Over the past decade, many studies have indicated that adolescence is a critical period of brain development and maturation. The refinement and maturation of the central nervous system over this prolonged period, however, makes the adolescent brain highly susceptible to perturbations from acute and chronic drug exposure. Here we review the preclinical literature addressing the long-term consequences of adolescent exposure to common recreational drugs and drugs-of-abuse. These studies on adolescent exposure to alcohol, nicotine, opioids, cannabinoids and psychostimulant drugs, such as cocaine and amphetamine, reveal a variety of long-lasting behavioral and neurobiological consequences. These agents can affect development of the prefrontal cortex and mesolimbic dopamine pathways and modify the reward systems, socio-emotional processing and cognition. Other consequences include disruption in working memory, anxiety disorders and an increased risk of subsequent drug abuse in adult life. Although preventive and control policies are a valuable approach to reduce the detrimental effects of drugs-of-abuse on the adolescent brain, a more profound understanding of their neurobiological impact can lead to improved strategies for the treatment and attenuation of the detrimental neuropsychiatric sequelae.
Smoking status and cognitive performance among vocational school students in Beijing, China
2018, Respiratory Medicine
In countries where smoking is associated with lower socioeconomic status, smokers tend to perform worse on cognitive tasks than non-smokers. China is now undergoing a similar process with a recent study showing that there is a reduced cognitive performance in middle aged but not in elderly smokers. We examined the links between smoking status and cognitive functioning among vocational school students in Beijing, China.
A total of 213 students aged 16–20 (98 smokers and 115 non-smokers) were recruited from three vocational schools in Beijing. Participants completed three subtests of Wechsler Adult Intelligence Scale (WAIS) (information, arithmetic, digit span) and Dysexecutive Questionnaire (DEX). Smokers also completed a cigarette smoking questionnaire and Fagerstrom Test of Nicotine Dependence (FTND).
Smokers performed worse than non-smokers in tests of arithmetic and digit span forward (t = 4.25, 2.05, both P < .05). Scores on digit span backward did not differentiate smokers and non-smokers, but among smokers, the performance on this subtest was related to the age of starting smoking (r = 0.26, p < .001). Cognitive performance in smokers was not related to tobacco dependence or intensity of smoking. Compared to non-smokers, smokers had a higher total DEX score and higher scores on three of its five subscales (Inhibition, Knowing–doing dissociation and Social regulation, all p < .05). Another subscale, In-resistance, did not differentiate smokers and non-smokers, but differentiated smokers with lower and higher levels of nicotine dependence (t = −2.12, p < .05).
Smokers performed worse on some cognitive tasks than non-smokers and scored higher on a questionnaire assessing executive dysfunction.
Intrauterine exposure to tobacco and executive functioning in high school
2017, Drug and Alcohol Dependence
Citation Excerpt :
IUTE was the only other intrauterine substance with independent effects on the caregiver-reported BRIEF, and that was for a single subscale (Monitoring) of Metacognition but not Behavioral Regulation subscales. In contrast with prior findings by this research group (Rose-Jacobs et al., 2011) and others (Fried et al., 2006; Squeglia et al., 2009; Tapert et al., 2002), the present study found that concurrent adolescent substance use was not related to EF ratings. This difference may be due to two reasons.
Executive functioning (EF), an umbrella construct encompassing gradual maturation of cognitive organization/management processes, is important to success in multiple settings including high school. Intrauterine tobacco exposure (IUTE) correlates with negative cognitive/behavioral outcomes, but little is known about its association with adolescent EF and information from real-life contexts is sparse. We evaluated the impact of IUTE on teacher-reported observations of EF in urban high school students controlling for covariates including other intrauterine and adolescent substance exposures.
A prospective low-income birth cohort (51% male; 89% African American/Caribbean) was followed through late adolescence (16–18 years old). At birth, intrauterine exposures to cocaine and other substances (52% cocaine, 52% tobacco, 26% marijuana, 26% alcohol) were identified by meconium and/or urine assays, and/or maternal self-report. High school teachers knowledgeable about the student and unaware of study aims were asked to complete the Behavior Rating Inventory of Executive Functioning-Teacher Form (BRIEF-TF) annually.
Teachers completed at least one BRIEF-TF for 131 adolescents. Multivariable analyses included controls for: demographics; intrauterine cocaine, marijuana, and alcohol exposures; early childhood exposures to lead; and violence exposure from school-age to adolescence. IUTE was associated with less optimal BRIEF-TF Behavioral Regulation scores (p <0.05). Other intrauterine substance exposures did not predict less optimal BRIEF-TF scores, nor did exposures to violence, lead, nor adolescents’ own substance use.
IUTE is associated with offspring’s less optimal EF. Prenatal counseling should emphasize abstinence from tobacco, as well as alcohol and illegal substances.
Cigarette smoke and related risk factors in neurological disorders: An update
2017, Biomedicine and Pharmacotherapy
Citation Excerpt :
Research findings on smoking-related NDs also bring into attention that smoking can directly induce cognitive impairment [24,25]. In a few other studies with young adults revealed that smokers were inferior to nonsmokers in terms of measures of continuous attention and impulse control [26] oral arithmetic, receptive and expressive vocabulary, auditory-verbal memory [27], information processing speed and general intelligence [28]. Besides, an experiment on behavioral measures of balloon analogue risk task revealed an increased level of risk taking in young adult smokers [28].
Cigarette smoking is known to be harmful to health, and is considered the main cause of death worldwide, especially in India. Among the well-distinguished diseases related to smoking are, chronic obstructive pulmonary disease, oral and peripheral cancers, and cardiovascular complications. However, the impact of cigarette smoking on neurocognitive and neuropathological effects, including anxiety, Alzheimer’s disease, Parkinson’s disease, ischemic stroke, and blood-brain barrier dysfunction, still remains unclear. Cigarette smoke consists of more than 4500 toxic chemicals that combine to form free radicals, which lead to oxidative stress-associated neurological disorders. Herein, we discuss the role of antioxidant agents in delaying or attenuating disease complications. In addition, in this review, we discuss the neuropathological effect of cigarette smoke and its interference in neurodegeneration.

View all citing articles on Scopus

View full text

Neurocognitive consequences of cigarette smoking in young adults—a comparison with pre-drug performance

Abstract

Introduction

Section snippets

Participants

Sample characteristics

Discussion

Acknowledgement

J. Clin. Epidemiol.

Neurotoxicol. Teratol.

Drug Alcohol Depend.

Neurotoxicol. Teratol.

Neurotoxicol. Teratol.

Neurotoxicol. Teratol.

Neurotoxicol. Teratol.

Biol. Psychiatry

Neurotoxicol. Teratol.

Hear. Res.

Neurotoxicol. Teratol.

Neurotox. Teratol.

Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations

Brain Res.

Diagnostic and Statistical Manual of Mental Disorders

Canadian Tobacco Use Monitoring Survey

Computerized NIMH-Diagnostic Interview Schedule for Children-Version IV (C-DISC 4)

Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak Project

J. Neurol. Neurosurg. Psychiatry

Prenatal tobacco exposure: is it a risk for early tobacco experimentation?

Nicotine Tob. Res.

Smoking and cognitive change from age 11 to age 80

J. Neurol. Neurosurg. Psychiatry

Prospective association of smoking and alcohol use with cognitive function in an elderly cohort

J. Women's Health

The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort

Arch. Neurol.

Smoking in pregnancy and development into early childhood

BMJ

Adolescents prenatally exposed to marijuana: Examination of facets of complex behaviors and comparison with the influence of in utero cigarettes

J. Clin. Pharmacol.

60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes and alcohol: Cognitive and language assessment

J. Dev. Behav. Pediatr.